Table 1—

Baseline characteristics of patients with diabetes

Baseline characteristic (at randomization)Atorvastatin 10 mgAtorvastatin 80 mg
n753748
Men544 (72.2)550 (73.5)
Age (years)62.8 ± 8.063.2 ± 7.9
Race
    White670 (89.0)670 (89.6)
    Black48 (6.4)39 (5.2)
    Other35 (4.6)39 (5.2)
Systolic blood pressure (mmHg)134.7 ± 17.3134.3 ± 17.6
Diastolic blood pressure (mmHg)76.8 ± 9.577.1 ± 9.9
BMI (kg/m2)30.7 ± 5.630.1 ± 5.0
Diabetes duration (years)8.3 ± 8.58.8 ± 8.8
Diabetes control
    Oral hypoglycemic drug only324 (43.0)326 (43.6)
    Insulin only101 (13.4)94 (12.6)
    Insulin + oral hypoglycemic drug157 (20.8)146 (19.5)
    No diabetes medications*171 (22.7)182 (24.3)
    Fasting plasma glucose (mg/dl)153.9 ± 49.3154.0 ± 49.9
    Plasma creatinine (mg/dl)1.19 ± 0.231.19 ± 0.25
    A1C (%)7.4 ± 1.37.4 ± 1.2
Cardiovascular history
    Angina606 (80.5)632 (84.5)
    Hypertension536 (71.2)525 (70.2)
    Former smoker484 (64.3)446 (59.6)
    Myocardial infarction414 (55.0)442 (59.1)
    Coronary artery bypass graft420 (55.8)403 (53.9)
    Coronary angioplasty370 (49.1)402 (53.7)
    Peripheral arterial disease151 (20.1)168 (22.5)
    Congestive heart failure105 (13.9)108 (14.4)
    Current smoker72 (9.6)86 (11.5)
    Cerebrovascular accident67 (8.9)68 (9.1)
Lipids
    LDL cholesterol
        mg/dl96.7 ± 17.895.6 ± 18.4
        mmol/l2.50 ± 0.462.47 ± 0.48
    Total cholesterol
        mg/dl174.9 ± 24.5174.7 ± 24.6
        mmol/l4.52 ± 0.634.52 ± 0.64
    Triglycerides
        mg/dl169.2 ± 78.9171.3 ± 80.9
        mmol/l1.91 ± 0.891.93 ± 0.91
    HDL cholesterol
        mg/dl44.6 ± 9.245.2 ± 11.1
        mmol/l1.15 ± 0.241.17 ± 0.29
    Apolipoprotein B113.6 ± 20.0112.5 ± 19.5
  • Data are means ± SD or n (%).

  • *

    * Patients who were not recorded as taking oral hypoglycemic agents or insulin at study entry.